Literature DB >> 10168036

Interferon-alpha in hepatitis C.

R S Koff.   

Abstract

Mesh：

Substances：

Year:  1997        PMID： 10168036     DOI： 10.2165/00019053-199711050-00010

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  2 in total

1.  Interferon-alpha in hepatitis C. Dosage, costs and benefits.

Authors:  A Briggs; A Shiell
Journal:  Pharmacoeconomics       Date:  1996-09       Impact factor: 4.981

2.  Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis.

Authors:  S Nishiguchi; T Kuroki; S Nakatani; H Morimoto; T Takeda; S Nakajima; S Shiomi; S Seki; K Kobayashi; S Otani
Journal:  Lancet       Date:  1995-10-21       Impact factor: 79.321
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.